AGP Executive Report
Last update: 6 hours agoDrug Safety: Amazon is recalling more than 112,000 bottles of its Basic Care acetaminophen after reports of discolored tablets; no related injuries have been reported. Obesity Research: Zealand Pharma and Generate Biomedicines struck an AI drug-development deal worth up to nearly $1.2 billion to create protein treatments for obesity and other metabolic diseases. Pharma Oversight: The FTC and seven states are asking a court to hold Martin Shkreli in contempt, alleging he breached a lifetime industry ban by trading pharmaceutical stocks and discussing drug companies. Maternal Health: A Columbia-led study found that extending Medicaid coverage to a year after childbirth increased follow-up care for women with pregnancy-related diabetes or hypertension. Medicare: Open enrollment starts Oct. 15; beneficiaries are urged to check 2027 drug coverage and watch for scams. Medicine Access: In Cuba, worsening shortages are pushing people to rely on free community pharmacies run by charities.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
